key: cord-1009729-rulp2rut
authors: Joseph, Adrienne K.; Chong, Benjamin F.
title: Subacute cutaneous lupus erythematosus flare triggered by COVID‐19 vaccine
date: 2021-09-06
journal: Dermatol Ther
DOI: 10.1111/dth.15114
sha: bf4acc72bc3ba9c921256373bb6f3cc04b5d714c
doc_id: 1009729
cord_uid: rulp2rut

nan

The most frequently reported adverse cutaneous reactions to messenger RNA (mRNA) derived COVID-19 vaccines include injection site reactions and findings related to anaphylaxis. [1] [2] [3] Little is known about COVID-19 vaccination in patients with autoimmune skin disease.

Here, we report a case of a subacute cutaneous lupus (SCLE) flare after COVID-19 immunization. 

Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine

Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine

Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine -United States

Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults

The role of cytokines in the pathogenesis of cutaneous lupus erythematosus

Pathophysiology of cutaneous lupus erythematosus

SARS-CoV-2 vaccines in patients with SLE

Vaccine Clinical Guidance Task Force. (2021) COVID-19 vaccine clinical guidance summary for patients with rheumatic and musculoskeletal diseases

American College of Rheumatology Guidance for COVID-19 vaccination in patients with rheumatic and musculoskeletal diseases: version 2